Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 22:10.1038/s41589-025-01894-4.
doi: 10.1038/s41589-025-01894-4. Online ahead of print.

TOM20-driven E3 ligase recruitment regulates mitochondrial dynamics through PLD6

Affiliations

TOM20-driven E3 ligase recruitment regulates mitochondrial dynamics through PLD6

Anat Raiff et al. Nat Chem Biol. .

Abstract

Mitochondrial homeostasis is maintained through complex regulatory mechanisms, including the balance of mitochondrial dynamics involving fusion and fission processes. A central player in this regulation is the ubiquitin-proteasome system (UPS), which controls the degradation of pivotal mitochondrial proteins. In this study, we identified cullin-RING E3 ligase 2 (CRL2) and its substrate receptor, FEM1B, as critical regulators of mitochondrial dynamics. Through proteomic analysis, we demonstrate here that FEM1B controls the turnover of PLD6, a key regulator of mitochondrial dynamics. Using structural and biochemical approaches, we show that FEM1B physically interacts with PLD6 and that this interaction is facilitated by the direct association of FEM1B with the mitochondrial import receptor TOM20. Ablation of FEM1B or disruption of the FEM1B-TOM20 interaction impairs PLD6 degradation and induces mitochondrial defects, phenocopying PLD6 overexpression. These findings underscore the importance of FEM1B in maintaining mitochondrial morphology and provide further mechanistic insights into how the UPS regulates mitochondrial homeostasis.

PubMed Disclaimer

Conflict of interest statement

Competing interests: The authors declare no competing interests.

References

    1. Spinelli JB & Haigis MC The multifaceted contributions of mitochondria to cellular metabolism. Nature Cell Biology 2018 20:7 20, 745–754 (2018). - PMC - PubMed
    1. Ng MYW, Wai T & Simonsen A Quality control of the mitochondrion. Dev Cell 56, 881–905 (2021). - PubMed
    1. Liu YJ, McIntyre RL, Janssens GE & Houtkooper RH Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease. Mech Ageing Dev 186, 111212 (2020). - PubMed
    1. Giacomello M, Pyakurel A, Glytsou C & Scorrano L The cell biology of mitochondrial membrane dynamics. Nature Reviews Molecular Cell Biology 2020 21:4 21, 204–224 (2020). - PubMed
    1. Nakamura N, Kimura Y, Tokuda M, Honda S & Hirose S MARCH-V is a novel mitofusin 2- and Drp1-binding protein able to change mitochondrial morphology. EMBO Rep 7, 1019–1022 (2006). - PMC - PubMed

METHODS-ONLY REFERENCES

    1. Makaros Y et al. Ubiquitin-independent proteasomal degradation driven by C-degron pathways. Mol Cell 83, 1921–1935.e7 (2023). - PMC - PubMed
    1. Timms RT et al. A glycine-specific N-degron pathway mediates the quality control of protein N -myristoylation. Science (1979) 365, eaaw4912 (2019). - PMC - PubMed
    1. Sanjana NE, Shalem O & Zhang F Improved vectors and genome-wide libraries for CRISPR screening. Nat Methods 11, 783–784 (2014). - PMC - PubMed
    1. Chaudhry A, Shi R & Luciani DS A pipeline for multidimensional confocal analysis of mitochondrial morphology, function, and dynamics in pancreatic β-cells. Am J Physiol Endocrinol Metab 318, E87–E101 (2020). - PMC - PubMed
    1. Wang Y et al. Reversed-phase chromatography with multiple fraction concatenation strategy for proteome profiling of human MCF10A cells. Proteomics 11, 2019–2026 (2011). - PMC - PubMed

LinkOut - more resources